Get started
Author

Osamu Shiraishi

Observed names: O Shiraishi, O. Shiraishi, O., Shiraishi, OSAMU SHIRAISHI, OSAMU SHIRAISI, Osamu SHIRAISHI, Osamu Shiraisi
Institution: Kindai University
ORCID: 0000-0002-4740-5422
Observed ORCID: 0000-0002-4740-5422
OpenAlex ID: A5059515844
Multicenter randomized phase II study of cisplatin and fluorouracil plus docetaxel (DCF) compared with cisplatin and fluorouracil plus Adriamycin (ACF) as preoperative chemotherapy for resectable esophageal squamous cell carcinoma (OGSG1003)
2016 · M. Yamasaki, T. Yasuda, et al. · Annals of Oncology · 129
PDF
Multicenter Phase I/II Study of Docetaxel, Cisplatin and Fluorouracil Combination Chemotherapy in Patients with Advanced or Recurrent Squamous Cell Carcinoma of the Esophagus
2011 · Makoto Yamasaki, Hiroshi Miyata, et al. · Oncology · 103
Randomized study of clinical effect of enteral nutrition support during neoadjuvant chemotherapy on chemotherapy-related toxicity in patients with esophageal cancer
2011 · Hiroshi Miyata, Masahiko Yano, et al. · Clinical Nutrition · 96
Gene amplification of EGFR, HER2, FGFR2 and MET in esophageal squamous cell carcinoma
2013 · HIROAKI KATO, TOKUZO ARAO, et al. · International Journal of Oncology · 90
PDF
Long-term Survival Outcomes of Advanced Gastric Cancer Patients Who Achieved a Pathological Complete Response with Neoadjuvant Chemotherapy: A Systematic Review of the Literature
2014 · Haruhiko Cho, Junichi Nakamura, et al. · Annals of Surgical Oncology · 75
Randomized study of the clinical effects of ω-3 fatty acid–containing enteral nutrition support during neoadjuvant chemotherapy on chemotherapy-related toxicity in patients with esophageal cancer
2016 · Hiroshi Miyata, Masahiko Yano, et al. · Nutrition · 56
Phase I clinical trial of vaccination with LY6K-derived peptide in patients with advanced gastric cancer
2013 · Hajime Ishikawa, Motohiro Imano, et al. · Gastric Cancer · 56
PDF
A newly modified esophagogastrostomy with a reliable angle of His by placing a gastric tube in the lower mediastinum in laparoscopy-assisted proximal gastrectomy
2014 · Atsushi Yasuda, Takushi Yasuda, et al. · Gastric Cancer · 51
PDF
Feasibility of Preoperative Chemotherapy with Docetaxel, Cisplatin, and 5-Fluorouracil versus Adriamycin, Cisplatin, and 5-Fluorouracil for Resectable Advanced Esophageal Cancer
2016 · Osamu Shiraishi, Makoto Yamasaki, et al. · Oncology · 44
Multicenter randomised trial of two versus three courses of preoperative cisplatin and fluorouracil plus docetaxel for locally advanced oesophageal squamous cell carcinoma
2022 · Tomoki Makino, Makoto Yamasaki, et al. · British Journal of Cancer · 40
Clinical effect of enteral nutrition support during neoadjuvant chemotherapy on the preservation of skeletal muscle mass in patients with esophageal cancer
2021 · Ryosuke Kita, Hiroshi Miyata, et al. · Clinical Nutrition · 36
Impact of Intraperitoneal Chemotherapy after Gastrectomy with Positive Cytological Findings in Peritoneal Washings
2011 · M. Imano, H. Imamoto, et al. · European Surgical Research · 35
Comparison of synbiotics combined with enteral nutrition and prophylactic antibiotics as supportive care in patients with esophageal cancer undergoing neoadjuvant chemotherapy: A multicenter randomized study
2022 · Masaaki Motoori, Keijiro Sugimura, et al. · Clinical Nutrition · 31
Impact of the Route of Reconstruction on Post‐operative Morbidity and Malnutrition after Esophagectomy: A Multicenter Cohort Study
2014 · Makoto Yamasaki, Hiroshi Miyata, et al. · World Journal of Surgery · 31
Chemoradiotherapy versus triplet chemotherapy as initial therapy for T4b esophageal cancer: survival results from a multicenter randomized Phase 2 trial
2023 · Makoto Yamasaki, Hiroshi Miyata, et al. · British Journal of Cancer · 27
PDF
Long‐term results of a randomized controlled trial comparing neoadjuvant Adriamycin, cisplatin, and 5‐fluorouracil vs docetaxel, cisplatin, and 5‐fluorouracil followed by surgery for esophageal cancer (OGSG1003)
2020 · Keijiro Sugimura, Makoto Yamasaki, et al. · Annals of Gastroenterological Surgery · 26
PDF
Risk Factors and Prognostic Impact of Mediastinal Lymph Node Metastases in Patients with Esophagogastric Junction Cancer
2020 · Osamu Shiraishi, Takushi Yasuda, et al. · Annals of Surgical Oncology · 25
High expression of epithelial cellular adhesion molecule in peritoneal metastasis of gastric cancer
2012 · Motohiro Imano, Tatsuki Itoh, et al. · Targeted Oncology · 25
Thoracic Duct Resection Has a Favorable Impact on Prognosis by Preventing Hematogenous Spread of Esophageal Cancer Cells: A Multi-institutional Analysis of 2269 Patients
2021 · Koji Tanaka, Makoto Yamasaki, et al. · Annals of Surgical Oncology · 24
Two versus three courses of preoperative cisplatin and fluorouracil plus docetaxel for treating locally advanced esophageal cancer: short-term outcomes of a multicenter randomized phase II trial
2021 · Osamu Shiraishi, Tomoki Makino, et al. · Esophagus · 23
Relationship between Immunological Parameters and the Severity of Neutropenia and Effect of Enteral Nutrition on Immune Status during Neoadjuvant Chemotherapy on Patients with Advanced Esophageal Cancer
2012 · Masaaki Motoori, Masahiko Yano, et al. · Oncology · 21
Intraperitoneal and Systemic Chemotherapy for Patients with Gastric Cancer with Peritoneal Metastasis: A Phase II Trial
2018 · MASAYUKI SHINKAI, MOTOHIRO IMANO, et al. · Anticancer Research · 18
PDF
Clinical Impact of Conversion Surgery After Induction Therapy for Esophageal Cancer with Synchronous Distant Metastasis: A Multi-institutional Retrospective Study
2024 · Keijiro Sugimura, Koji Tanaka, et al. · Annals of Surgical Oncology · 17
Gut microbiota associated with the mitigation effect of synbiotics on adverse events of neoadjuvant chemotherapy in patients with esophageal cancer: A retrospective exploratory study
2023 · Takuya Sugimoto, Satomi Atobe, et al. · Journal of Medical Microbiology · 17
Comparison of Aggressive Planned Salvage Surgery Versus Neoadjuvant Chemoradiotherapy Plus Surgery for Borderline Resectable T4 Squamous Cell Carcinoma
2021 · Osamu Shiraishi, Takushi Yasuda, et al. · Annals of Surgical Oncology · 16
Works count: 154
Citation count: 1,479
H-index: 21
I10-index: 39
Year
Topic
Type